Tranexamic Acid (Athenex Pharmaceutical Division, LLC.)
Welcome to the PulseAid listing for the Tranexamic Acid drug offered from Athenex Pharmaceutical Division, LLC.. This Antifibrinolytic Agent [EPC],Decreased Fibrinolysis [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Athenex Pharmaceutical Division, LLC. |
| NON-PROPRIETARY NAME: | tranexamic acid |
| SUBSTANCE NAME: | TRANEXAMIC ACID |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Antifibrinolytic Agent [EPC],Decreased Fibrinolysis [PE] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-03-27 |
| END MARKETING DATE: | 0000-00-00 |
Tranexamic Acid HUMAN PRESCRIPTION DRUG Details:
| Item Description | Tranexamic Acid from Athenex Pharmaceutical Division, LLC. |
| LABELER NAME: | Athenex Pharmaceutical Division, LLC. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 100(mg/mL) |
| START MARKETING DATE: | 2017-03-27 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 70860-400_e1d19f4b-f03f-4b74-a5d6-2c7223005d30 |
| PRODUCT NDC: | 70860-400 |
| APPLICATION NUMBER: | ANDA207239 |
Other TRANEXAMIC ACID Pharmaceutical Manufacturers / Labelers:
